Skip to main content

Rheumatoid Arthritis

      RT @KDAO2011: #EULAR2020 OP0020: RABBIT 5500 pt study of all DMARDS/biologics, IL-6 inh may be the best to improve fatig

      k dao KDAO2011

      5 years 3 months ago
      #EULAR2020 OP0020: RABBIT 5500 pt study of all DMARDS/biologics, IL-6 inh may be the best to improve fatigue seen in RA patients @rheumnow https://t.co/VJW8MwMamM
      RT @KDAO2011: How long should you keep pts on TCZ for GCA after remission has been achieved? @RheumNow #eular2020

      k dao KDAO2011

      5 years 3 months ago
      How long should you keep pts on TCZ for GCA after remission has been achieved? @RheumNow #eular2020
      RT @KDAO2011: #EULAR2020 Dr. Kimme Hyrich reviews the EULAR #COVID19 Registry "Most individuals with rheumatic diseases

      k dao KDAO2011

      5 years 3 months ago
      #EULAR2020 Dr. Kimme Hyrich reviews the EULAR #COVID19 Registry "Most individuals with rheumatic diseases receiving immunosuppressive therapies recover from COVID19" @rheumnow https://t.co/EdVLUMyHhF
      RT @KDAO2011: #EULAR2020 panel on #COVID19 spec. situatns:
      1. German regtry: very few preg rheum pts w/CV19; cases mild

      k dao KDAO2011

      5 years 3 months ago
      #EULAR2020 panel on #COVID19 spec. situatns: 1. German regtry: very few preg rheum pts w/CV19; cases mild. 2. No info how CV19 affects APS 3. Very few ped rheum cases of CV19- cases mild; outcomes sim to gen peds pop 4. Most rheum pts w/CV19 good prognosis @rheumnow https://t.co/LQVdzJKCgu
      RT @uptoTate: 10 ReA pt study out of India reviewing ETN-b found that all pts (previously on ETN) responded to biosimila

      Dr. Rachel Tate uptoTate

      5 years 3 months ago
      10 ReA pt study out of India reviewing ETN-b found that all pts (previously on ETN) responded to biosimilar med without new safety signals. Further details are here on abstract #AB0632 https://t.co/lRA2IDvU4H #EULAR2020 @RheumNow https://t.co/QyhwBzBBH3
      RT @drdavidliew: Does TCZ actually fix GCA?
      @nihrheumatology cohort w serial PET/CT q6m:
      FDG uptake (PETVAS) reduces lon

      David Liew drdavidliew

      5 years 3 months ago
      Does TCZ actually fix GCA? @nihrheumatology cohort w serial PET/CT q6m: FDG uptake (PETVAS) reduces longitudinally over 2y but does not normalise, w rebound on TCZ cessation Ongoing reductions in year 2? GCA doesn't sleep. @KQuinnRheum @petercgrayson OP0144 #EULAR2020 @RheumNow https://t.co/aczQbONcNc
      In difficult times, it's reassuring to reflect on the similarities that bring us together. In the case of the EULAR and ACR COVID19 guidelines as discussed at #EULAR2020 by Drs. Mikuls and Landewe, the recommendations from both panels proved to be reassuring with a hint of "we are flying blindly into the unknown."
      This week's Tuesday Nite Rheumatology featured Dr Jonathan Kay (U Mass) who gave an update on Biosimilars and took questions the subject. The program was moderated by Dr. Jack Cush.
      ×